Cipla Enters Into Licensing Agreement With US Company For Key Covid Drug - 24HoursBharat.Com

Sunday, 9 May 2021

Cipla Enters Into Licensing Agreement With US Company For Key Covid Drug

Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19...

from NDTV News - Special https://ift.tt/3vLxZQ6

No comments:

Post a Comment

Post Top Ad

Your Ad Spot